[HTML][HTML] Selenium and thyroid diseases
F Wang, C Li, S Li, L Cui, J Zhao, L Liao - Frontiers in Endocrinology, 2023 - frontiersin.org
Selenium, a non-metallic element, is a micronutrient essential for the biosynthesis of
selenoproteins containing selenocysteine. In adults, the thyroid contains the highest amount …
selenoproteins containing selenocysteine. In adults, the thyroid contains the highest amount …
Papillary thyroid carcinoma: current position in epidemiology, genomics, and classification
AK Lam - Papillary Thyroid Carcinoma: Methods and Protocols, 2022 - Springer
Papillary thyroid carcinoma is the most common type of thyroid malignancy both in adults
and pediatric population. Since the 1980s, there are changes in criteria in labelling thyroid …
and pediatric population. Since the 1980s, there are changes in criteria in labelling thyroid …
[HTML][HTML] Nomogram model based on preoperative serum thyroglobulin and clinical characteristics of papillary thyroid carcinoma to predict cervical lymph node …
Q Chang, J Zhang, Y Wang, H Li, X Du… - Frontiers in …, 2022 - frontiersin.org
Objective Preoperative evaluation of cervical lymph node metastasis (LNM) in papillary
thyroid carcinoma (PTC) has been one of the serious clinical challenges. The present study …
thyroid carcinoma (PTC) has been one of the serious clinical challenges. The present study …
[HTML][HTML] LncRNA HOTAIR impairs the prognosis of papillary thyroid cancer via regulating cellular malignancy and epigenetically suppressing DLX1
Purpose Papillary thyroid cancer (PTC) is the most common endocrine malignancy with a
fast-growing incidence in recent decades. HOTAIR as a long non-coding RNA has been …
fast-growing incidence in recent decades. HOTAIR as a long non-coding RNA has been …
[HTML][HTML] Risk-stratified papillary thyroid microcarcinoma: post-operative management and treatment outcome in a single center
W Kanokwongnuwat, N Larbcharoensub… - Endocrine, 2022 - Springer
Purpose This article aims to review and assess the post-operative management and
treatment outcomes of papillary thyroid microcarcinoma (PTMC) in risk-stratified patients …
treatment outcomes of papillary thyroid microcarcinoma (PTMC) in risk-stratified patients …
Ablation of Primary and Recurrent Thyroid Cancer: Current and Future Perspectives
T Freeman, O Pena, AA Sag… - Seminars in …, 2024 - thieme-connect.com
Thyroid cancer is the most common endocrine malignancy, and its incidence is increasing,
driven in part by the advent of ultrasound, and subsequent increased detection of small …
driven in part by the advent of ultrasound, and subsequent increased detection of small …
[HTML][HTML] Nomogram for predicting skip metastasis in cN0 papillary thyroid cancer patients at increased risk of lymph node metastasis
F Li, FJ Zhou, TW Zhu, HL Qiu… - … in Clinical and …, 2023 - advances.umw.edu.pl
Background. Skip lymph node metastasis (SLNM) refers to lateral lymph node metastasis
(LLNM) without involving central lymph node (CLN). Some microscopic nodal positivity may …
(LLNM) without involving central lymph node (CLN). Some microscopic nodal positivity may …
Clinical significance of circulating tumor cells (CTCs) and survivin on predicting prognosis in thyroid cancer patients
X Weng, YangYang, Y Cai - Disease Markers, 2022 - Wiley Online Library
Background. Clinical significance of circulating tumor cell (CTC) count, mesenchymal CTCs
(MCTCs), and survivin in patients with thyroid cancer remains unclear. We evaluated the …
(MCTCs), and survivin in patients with thyroid cancer remains unclear. We evaluated the …
Myo-inositol for subclinical hypothyroidism and potential prevention of thyroid tumors
D Barbaro, G Porcaro, S Benvenga - A Clinical Guide to Inositols, 2023 - Elsevier
Inositols and myo-inositol in particular might influence the functioning of the thyroid, by
regulating the activity and replication of the thyrocytes. Inositols are well-known second …
regulating the activity and replication of the thyrocytes. Inositols are well-known second …
131I在复发性甲状腺乳头状癌临床诊治中的价值
景正军, 张亚奇, 别爽, 樊倩妤, 陈健 - 肿瘤防治研究, 2022 - zlfzyj.com
甲状腺乳头状癌(PTC) 总体预后良好, 但首次治疗后仍可能有高达20%~ 30% 的患者复发,
并因此导致预后不良和治疗困难. 131 I 是初治中高危风险PTC 患者术后重要的辅助治疗手段 …
并因此导致预后不良和治疗困难. 131 I 是初治中高危风险PTC 患者术后重要的辅助治疗手段 …